Furthermore, loss-of-function mutations, LOH, or decreased expression of the MCC gene are also detected in a number of other human cancers, including lung cancer [17,23], gastric carcinoma [24], esophageal cancer [25], and hepatocellular carcinoma [26,27]. This evidence concerns the gene MCC and cancer.